Tacrolimus for Treating Orbital and Cranial Form of Idiopathic Inflammatory Pseudotumors
Journal of Clinical Neurology
;
: 674-680, 2020.
Article
| WPRIM
| ID: wpr-833661
ABSTRACT
Background@#and Purpose:
Orbital and cranial form of idiopathic inflammatory pseudotumors (IIPs) are rare disorders with heterogeneous clinical presentations. Corticosteroids have been the first-line treatment for IIPs, but they are not always effective. @*Methods@#We reviewed the medical records of three patients with orbital or cranial form of IIP who were treated with tacrolimus as an adjuvant treatment. @*Results@#The three patients showed favorable outcomes with the addition of tacrolimus, which is a calcineurin inhibitor that inhibits T-cell activation and T-cell-dependent B-cell activation. @*Conclusions@#Tacrolimus may be a safe and effective immunosuppressant for refractory or relapsing form of orbital or cranial IIPs.
Full text:
Available
Index:
WPRIM (Western Pacific)
Journal:
Journal of Clinical Neurology
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS